Enacted on Novemver 30^th 2021
Revised on March 1^st 2023 (2^nd Revision)

Journal of Neuromonitoring & Neurophysiology (JNN) is a peer-reviewed open access journal published biannually on the 30th of May, and November. The aims of the journal are to publish articles of clinical and basic research related to intraoperative neuromonitoring and neurophysiology, and eventually enhance synergistic effect of multidisciplinary research.

Manuscripts should be prepared for submission to JNN according to the following instructions. JNN adheres to the guidelines and best practices published by professional organizations, including “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” from International Committee of Medical Journal Editors (ICMJE; https://www.icmje.org/) and “Principles of Transparency and Best Practice in Scholarly Publishing” from Committee on Publication Ethics (COPE; https://publicationethics.org/), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME) (https://doaj.org/bestpractice) if otherwise not described below.

CATEGORIES OF PUBLICATIONS

Article types are full-length Review Articles, Original articles, Case reports.
Reviews are usually solicited by the Editor-in-Chief and describe concise review on subjects of importance to medical researchers.
Original articles are papers containing results of basic and clinical investigations, which are sufficiently well documented to be acceptable to critical readers.
Case reports as well as brief communications deal with issues of importance to medical researchers.

EDITORIAL POLICIES

The Editorial Board committed to complying with publication ethics. Except for the negotiated secondary publication, manuscripts submitted to the Journal must be previously unpublished and not be under consideration for publication elsewhere. If a new author should be added or an author should be deleted after the submission, it is the responsibility of the all authors. JNN has no responsibility for such changes. All published manuscripts become the permanent property of the Korean Intraoperative Neural Monitoring Society and may not be published elsewhere without written permission. The anonymity of reviewers is preserved.

RESEARCH AND PUBLICATION ETHICS

For the policies on the research and publication ethics not stated in this instruction, “Good Publication Practice Guidelines for Medical Journals from the Korean Association of Medical Journal Editors (https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13&per_page=)” or “COPE Core Practices (https://publicationethics.org/core-practices)” can be applied.

Authorship

It is important to understand that authorship credit should be based on (1) substantial contributions to conception and design, acquisition of data, and/or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Every author should meet all of these four conditions for every submitted manuscript to JNN. Those who do not meet all four criteria should be acknowledged as contributors. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. When a several group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship.
After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author. JNN does not correct authorship after publication unless a mistake has been made by the editorial staff.

Statements of Human and Animal Rights, Informed Consent, and Institutional Review Board Approval

All of the manuscripts should be prepared in strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org/), ICMJE (http://www.icmje.org/), and WAME (http://www.wame.org/). Any study including human subjects or human data must be reviewed and approved by a responsible Institutional Review Board (IRB). Please refer to the principles embodied in the Declaration of Helsinki (2013, https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/) for all investigations involving human materials. A written informed consent must be obtained from all subjects involved and should be indicated in the submitted article. Patient anonymity must be preserved and confidential information should not be published. If identifying information is essential for scientific purposes, authors must provide a signed statement from the patient granting approval for the publication of identifying materials, including photographs.
Animal experiments also should be approved by Institutional Animal Care and Use Committee for the care and use of animals. Also studies with pathogens requiring a high degree of biosafety should be approved by Institutional Biosafety Committee.
If necessary, the editor or reviewers may request copies of these documents to resolve any questions regarding IRB approval and study conduct.

Obligation to Register Clinical Trial

Clinical trial defined as “any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome” should be registered to the primary registry to be prior publication. JNN accepts the registration in any of the primary registries that participate in the World Health Organization International Clinical Trials Portal (http://www.who.int/ictrp/en/), National Institute of Health ClinicalTrials.gov (http://www.clinicaltrials.gov/), International Standard Randomised Controlled Trial Number Register Resister (www.ISRCTN.org), University Hospital Medical Information Network (https://www.umin.ac.jp/ctr/index.htm).

Data Sharing Policy

This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement as described below. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial’s registration. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit data sharing plan. Based on the degree of sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site.

Sex and Gender

The term sex should be used when reporting biological factors and gender should be used when reporting gender identity or psychosocial/cultural factors. The methods used to obtain information on sex, gender, or both (e.g., self-reported, investigator observed or classified, or laboratory test) should be explained in the Materials and Methods section. If only one sex is reported, or included in the study, the reason the other sex is not reported or included should be explained in the Materials and Methods section, except for studies of diseases/disorders that only affect males (e.g., diseases involving male genitalia) or females (e.g., diseases involving female genitalia).

Conflict of Interest

The corresponding author of an article is asked to inform the Editor of the authors’ potential conflicts of interest possibly influencing their interpretation of data. A potential conflict of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may be financial support (employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications, and travel grants) or other relationships (academic or even personal) with commercial entities whose products or services are related to the subject matter in the manuscript, or sociopolitical issues that can cause conflict. Disclosure form shall be same with ICMJE Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/coi_disclosure.pdf). The Editor will decide whether the information on the conflict should be included in the published paper. In particular, all sources of funding for a research should be explicitly stated.

Redundant Publication and Plagiarism

Submitted manuscripts must not have been previously published in any context, or be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other journal without the express written permission of the Editorial Board. This restriction does not apply to abstracts or press reports published in connection with scientific meetings.
Submitted manuscripts are screened for possible plagiarism or duplicate publication by the use of Similarity Check upon arrival. If plagiarism or duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutions will be informed of this situation. There will also be penalties that will be assessed and applied for the authors if this incident occurs.
A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced or considered for reproduction by JNN. This requirement applies to text, figures, and tables.

Secondary Publication

Process for Managing Research and Publication Misconduct

MANUSCRIPT PREPARATION

Reporting guidelines for specific study designs

Research reports frequently omit important information. As such, reporting guidelines have been developed for a number of study designs that some journals may ask authors to follow. Authors are encouraged to also consult the reporting guidelines relevant to their specific research design. A good source of reporting guidelines is the EQUATOR Network (http://www.equator-network.org/home/) and the United States National Institutes of Health/National Library of Medicine (http://www.nlm.nih.gov/services/research_report_guide.html).

General

Title Page

This should contain the title of an article, full names, institutional affiliations, ORCIDs, conflicts of interest, and contributions of all authors. Institutions should be clearly indicated with which department and institution each author is affiliated. In a separate paragraph, the name of corresponding author, degree, E-mail address, and ORCID should be given. The corresponding author will receive all correspondence regarding the manuscript, as well as proof pages, reprint requests. Also indicate where the paper was presented, and if applicable, provide acknowledgments of any grants and/or other assistance received. A running title, 50 characters or less including blank, should not be declarative or interrogative sentences.

Acknowledgments

All persons who have made substantial contribution, but who are not eligible as authors are named in acknowledgment.

Conflict of Interest

Any potential conflict of interest that may influence the results or the conclusion derived from the study should be disclosed. If the authors have nothing to disclose, please state: “No potential conflict of interest relevant to this article was reported.”

Funding

Funding to the research should be provided. Providing a FundRef ID is recommended including the name of the funding agency, country and if available, the number of the grant provided by the funding agency. If the funding agency does not have a FundRef ID, please ask that agency to contact the FundRef registry (e-mail: fundref.registry@crossref.org).

ORCID (Open Researcher and Contributor ID)

Authors are recommended to provide an ORCID. To obtain an ORCID, authors should register in the ORCID website: http://orcid.org. Registration is free to every researcher in the world.

Author Contributions

Enter all author contributions in the submission system during submission. The contributions of all authors must be described using the CRediT Taxonomy of author roles. To qualify for authorship, all contributors must meet at least one of the seven core contributions (conceptualization, methodology, software, validation, formal analysis, investigation, and data curation), as well as at least one of the writing contributions (original draft preparation, review, and editing). The corresponding author is responsible for completing this information at submission, and it is expected that all authors will have reviewed, discussed, and agreed to their individual contributions prior to manuscript submission.
Examples of author contributions are as follows: Conceptualization: OOO. Data curation: OOO. Formal analysis: OOO. Funding acquisition: OOO. Investigation: OOO. Methodology: OOO. Project administration: OOO. Software: OOO. Validation: OOO. Visualization: OOO. Writing–original draft: OOO. Writing– review & editing: all authors.

Abstract and Key Words

Abstract must be organized and formatted according to the following headings: (1) Background and Objectives, (2) Materials (Subjects) and Methods, (3) Results, and (4) Conclusion. The Abstract length is typically 250 words in English. Up to five keywords should be listed at the bottom of abstract to be used as index terms. For the selection of keywords, refer Medical Subject Heading (MeSH) in PubMed (https://meshb.nlm.nih.gov/search). If suitable MeSH terms are not yet available for recently introduced terms, present terms may be used.

Original Article

The text is to be divided into four sections with the following headings: Introduction, Materials (Subjects) and Methods, Results, Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer’s name. Maximum length of manuscript is 3,500 words in English (exclusive of the title page and abstract), 30 references and a total 10 images.

Introduction

Brief background, references to the most pertinent papers generally enough to inform readers, and relevant findings of others are described. The specific question to which the authors’ particular investigation is studied should be also described.

Materials (Subjects) and Methods

Explanation of the experimental methods should be concise and sufficient for repetition by other qualified investigators.
Present an “Ethics statement” immediately after the heading “Materials (Subjects) and Methods” in a boxed format.
Examples of Ethics statement are as follows:
1) This study was approved by the Institutional Review Board of OOO University (IRB-000000-0000-00). Informed consent was obtained from the participants.
2) Obtaining informed consent was exempted by the Institutional Review Board of OOO University (IRB-000000-0000-00) because there was no sensitive information and the survey was anonymously treated.
Procedures that have been published previously should not be described in detail. However, new or significant modifications of previously published procedures need full descriptions. The sources of special chemicals or preparations should be given along with the name of company. Method of statistical analyses and criteria of significance level should be described. In Case Reports, case history or case description replace the Materials and Methods section as well as Results section.

Results

This part should be presented logically using text, table and illustrations. Excessive repetition of table or figure contents should be avoided. At the end of results, emphasize or summarize only important observations.

Discussion

The data should be interpreted concisely without repeating materials already presented in the results section. Speculation is permitted, but it must be supported by the presented data of authors and be well founded.

References

Table

Tables must be cited in the order in which they appear in the text using Arabic numerals. The table’s footnote may include any pertinent notes and must include definitions of all abbreviations and acronyms that have been used in the table. Tables submitted with multiple parts will be renumbered. The significance of results should be indicated by appropriate statistical analysis. For footnotes use the following symbols, in sequence: a), b). All units of measurement and concentration should be designated. If you use data from another published or unpublished source, obtain permission and acknowledge them fully.

Figure

Figures must be cited in the order they appear in the text using Arabic numerals. Figure legends should appear within the document in a separate section after the references. Figure legends are required for all article types and should be double-spaced in the manuscript. All relevant and explanatory information extraneous to the actual figure, including figure part labels, footnotes, abbreviations, acronyms, arrows, and levels of magnification in insets, should be defined in the legend text. If figures have multiple parts (e.g., A, B, C, D), each part must be counted as a separate image in the total number allowed. Submit a photograph that will not reveal the person’s identity. Figures must be submitted as separate files saved in JPEG, TIFF, GIF, EPS, or PPT format (do not embedded the figures in the Microsoft Word manuscript file). The figure resolution should be at least 600 dpi for grayscale and color images, and 1,200 dpi for line figures at final size. Color images must be saved in CMYK mode (and not in RGB mode).

Review Article

The submission of review articles should describe concise review on subjects of importance to medical researchers. There should be an unstructured abstract of no more than 200 words. Maximum length of the submitted manuscript is 4,500 words. The text is to be divided into three sections with the following headings: Introduction, text (free heading), and Conclusion. The review articles are accepted after editorial evaluation.

Case Report

There should be an unstructured abstract of no more than 150 words. Maximum length of the submitted manuscript is 1,500 words, 15 references, and a total four authors. The text is to be divided into three sections with the following headings: Introduction, Case report, Discussion.

※ Other requirements are in accordance with the ICMJE, Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, (https://www.icmje.org/icmje-recommendations.pdf).

PUBLICATION PROCESS

Submission

Authors must submit their manuscript through our submission service website (http://submission.jnn.or.kr/) and the instructions should be closely followed. Notification of the disposition of each manuscript will be sent by E-mail to the corresponding author on the day of decision.

Screening before Review

If the manuscript does not fit the aims and scope of the Journal, or does not adhere to the Instructions to Authors, it may be returned to the author immediately after receipt and without a review from the publisher. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.ithenticate.com/), a plagiarism screening tool. The settings for the Similarity Check screening works as follows: The tool excludes information from the total score of the reviewed manuscript which are quotes, the bibliography, any small matches of six words that are deemed to be similar, small sources of 1%, and the Materials and Methods section of the study.

Peer Review

A manuscript is sent to the two most relevant investigators for a thorough review of the contents. The editor selects peer referees by recommendation of the Editorial Board members, or from the specialist database owned by the Editorial Board. For this review, the names and affiliations of the authors are blinded as a process. JNN adopts double blind review which means that the reviewer can not identify author information and authors can not identify reviewers, too. A manuscript is also reviewed for Korean or English. The peer review period is within 2 to 4 weeks. Acceptance of the manuscript is decided based on the critiques and recommended decision of the referees. The Editor may send the manuscript to another referee for additional comments and a recommended decision in that case. Three repeated decisions of “review after revision” are regarded as “rejection.” The reviewed manuscripts are returned back to the corresponding author with accompanying comments and recommended revisions. The names and decisions of the referees are masked and are not provided to the submitting party. A final decision on acceptance or rejection of the manuscript for publication is forwarded to the corresponding author from the Editorial Office. Failure to resubmit the revised manuscript within 2 months after peer review is regarded as a withdrawal. The corresponding author must indicate clearly what alterations have been made in response to the referee’s comments on a point by point basis. The author should resubmit any acceptable reasons which would be given for explaining the noncompliance with any recommendation of the referees.
All manuscripts from editors, employees, or members of the editorial board are processed the same way as other unsolicited manuscripts. During the review process, they will not engage in the selection of reviewers and decision process. Editors will not handle their own manuscripts even if they are commissioned ones.

Feedback after Publication

If the authors or readers find any errors, or contents that should be revised, it can be requested from the Editorial Board. The Editorial Board may consider erratum, corrigendum or a retraction. If there are any revisions to the article, there will be a CrossMark description to announce the final draft.

Process for Appeals

The policy of journal is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal. Appeals can be submitted to jnn.kinmos@gmail.com. If appeals arrive at the editorial office, it is discussed by the editorial board members. The results will be dispatched to submitter. Otherwise, the process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics available from: https://publicationethics.org/appeals.

COPYRIGHT AND PAYMENT INFORMATION

Copyright

Korean Intraoperative Neural Monitoring Society reserves the right to exclusive publication of all accepted manuscripts. Upon acceptance of an article, authors will be asked to transfer copyright. The corresponding author should upload a signed copyright transfer which has all authors sign on pages. This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding author confirming receipt of the manuscript. A form facilitating transfer of copyright will be provided. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.

Open Access

Articles published in JNN are open access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and the reproduction in any medium, provided that the original work is properly cited. For any commercial use of material from the open access version of the journal, permission must be obtained from JNN(Email: jnn.kinmos@gmail.com).

Archiving Policy

According to the deposit policy (self-archiving policy) of Sherpa/Romeo (http://www.sherpa.ac.uk/), authors cannot archive pre-print (i.e., pre-refereeing), but they can archive post-print (i.e., final draft post-refereeing). Authors can archive publisher’s version/PDF. JNN provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in Korea Citation Index and National Library of Korea.

Clinical Data Sharing Policy

All manuscript reporting clinical trial results should submit a data sharing statement. After acceptance, the corresponding authors of the accepted research articles are requested to submit the datasets underlying the results of this paper to the editorial office. If the data cannot be publicized, the reason should be described.

Article Processing Charge

There are no author submission fees or other publication-related charges. All costs for the publication process are shouldered by the Korean Intraoperative Neural Monitoring Society. The hard copy of the journal is printed in black and white. Color images and color diagrams will appear only in the online version as color images and color diagrams. If the authors like to appear the color images and color diagrams in color in the printed version, an additional fee will be charged based on that request. Authors may request additional reprints of their articles, in which case additional charges may be applied. Revenue sources of journal are from the support of the Korean Intraoperative Neural Monitoring Society and advertising rates.

EDITORIAL OFFICE

Editor-in-Chief
Seung Hoon Woo, MD, PhD
Dankook University Hospital, 201 Manghyang-ro, Dongnam-gu, Cheonan 31116, Korea
Tel: +82-41-529-6050, Fax: +82-41-559-7838
E-mail: jnn.kinmos@gmail.com
Website: http://www.jnn.or.kr/